Company profile: BioCardia
1.1 - Company Overview
Company description
- Provider of clinical-stage regenerative cardiology therapies and delivery systems, including CardiAMP autologous bone marrow cell therapy for heart failure, CardiALLO allogeneic mesenchymal stem cell therapy, the Helix system for minimally invasive biologic delivery to the heart, Morph DNA FDA-approved steerable introducer sheaths for cardiac/peripheral procedures, and the AVANCE bi-directional steerable introducer.
Products and services
- CardiAMP Cell Therapy: Autologous therapy that uses a patient's bone marrow cells, prepared at the bedside and delivered directly to the heart for treating heart failure
- CardiALLO Cell Therapy: Allogeneic mesenchymal stem cell therapy for heart failure, employing bone marrow-derived cells for cardiac treatment
- Helix Biotherapeutic Delivery System: Minimally invasive platform enabling delivery of biologic agents directly to the heart during cardiac procedures
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BioCardia
Luminetx
HQ: United States
Website
- Description: Provider of bioscience technologies, including the VeinViewer Imaging System that images vascular structures, allowing healthcare professionals to clearly see accessible vasculature in real time on the skin surface.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Luminetx company profile →
InteloMed
HQ: United States
Website
- Description: Provider of non-invasive, real-time cardiopulmonary monitoring solutions. Offers InteloMed TeleHealth Technology that uses facial scans during virtual consultations to deliver pulse and respiration metrics to clinicians. Engages in a NASA-supported project to develop non-contact monitoring for personnel and conducts an IRB-reviewed clinical study to validate its algorithms against traditional methods.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InteloMed company profile →
CHF Solutions
HQ: United States
Website
- Description: Provider of innovative cardiac care medical devices, designing and manufacturing a device that removes excess fluid from patients with fluid overload, offering practical solutions to address unmet clinical needs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CHF Solutions company profile →
VasoMedical
HQ: United States
Website
- Description: Provider of non-invasive cardiovascular medical devices and patient monitoring systems, including EECP Therapy Systems for coronary artery disease and ischemic heart failure; the Lumenair All-In-One EECP system; MobiCare wireless multi-parameter patient monitoring; and VasoMedical-BIOX 2301/2303/2305 2-in-1 ECG Holter and ambulatory blood pressure monitoring recorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full VasoMedical company profile →
Enchannel
HQ: China
Website
- Description: Provider of one-stop atrial fibrillation treatment solutions, offering the NanoAblate pulsed field ablation generator for non-thermal cardiac ablation; PFLine and PFBasket ablation catheters for flexible lesion sets and pulmonary vein isolation; and the DePolar 4D cardiac mapping system with DipperStar and LibStar catheters for real-time, high-resolution mapping.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enchannel company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BioCardia
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BioCardia
2.2 - Growth funds investing in similar companies to BioCardia
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BioCardia
4.2 - Public trading comparable groups for BioCardia
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →